Erratum: Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2 (Journal of Clinical Investigation (2017) 127:8 (3075-3089) DOI: 10.1172/JCI89092)

At the request of the corresponding author, the JCI is retracting this article. Several concerns were raised regarding the Western blot data in Figures 1J, 2A, 3A, and 4D and Supplemental Figures 3A, 4C, and 6A. After an extensive internal review, it became apparent that errors were introduced during the preparation of the revised figures. Due to loss of confidence in the published figures, the corresponding author requested retraction. No issues have been raised with regard to any of the other data in the paper.